搜索筛选:
搜索耗时1.0873秒,为你在为你在102,285,761篇论文里面共找到 34 篇相符的论文内容
发布年度:
Conditional disease-free survival in high risk localized renal cell carcinoma treated with or withou
[会议论文] 作者：Ning Shao,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
Development and validation of lncRNAs-based nomogram for prediction of biochemical recurrence in pro
[会议论文] 作者：Ning Shao,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
Neoadjuvant Sunitinib Treatment Prior to Planned Nephrectomy in Patients with Advanced Renal Cell Ca
[会议论文] 作者：Hua Xu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
SPOP Promotes SRRM1 Ubiquitination and Degradation to Suppress Prostate Cancer Progression by regula
[会议论文] 作者：jian ma,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
Objective Prostate cancer accounts for 19%of estimated new cancer cases in men and is the third primary cause of male cancer-related mortality after lung cancer and colon cancer in United States....
Targeting BCL2 to increase enzalutamide sensitivity to better suppress prostate cancer progression t
[会议论文] 作者：Hua Xu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
Objective Androgen deprivation therapy(ADT)with antiandrogens targeting androgens/androgen receptor(AR)signaling is the standard used to treat prostate cancer in different clinical settings besides su...
[会议论文] 作者：Yu Wei,Yao Zhu,DingWei Ye,
来源：2019中国肿瘤学大会 年份：2019
Objective Prostate cancer is a worldwide most occurred malignancy in male population....
[会议论文] 作者：Jun Wang,Yao Zhu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
[会议论文] 作者：Jun Wang,Yao Zhu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
Prognosis of adrenal neuroblastoma and conditional probability survival analysis based upon populati
[会议论文] 作者：wenjun xiao,Yao Zhu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
Objective Neuroblastoma(NB)is the most common extracranial solid tumor in children,with approximately 650 cases per year in the United States.Over half of children with neuroblastoma present with meta...
[会议论文] 作者：Beihe Wang,Yao Zhu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
[会议论文] 作者：Junlong Wu,Yao Zhu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
Germline DNA damage repair gene mutation landscape and clinical relevance in early-onset upper tract
[会议论文] 作者：Junlong Wu,Chengyuan Gu,Shengming Jin,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
Construction of a multi-gene signature for predicting prognosis in stage Ⅲ clear cell renal cell car
[会议论文] 作者：SHENGMING JIN,JUNLONG WU,WEIJIE GU,DINGWEI YE,
来源：2019中国肿瘤学大会 年份：2019
Objective Currently,obvious survival differences exist between the subgroups of stage Ⅲ RCC patients.Therefore,better signatures are required to help predict prognosis for stage Ⅲ RCC patients....
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer
[会议论文] 作者：jian ma,Dingwei Ye,Yuqian Yan,Haojie Huang,
来源：2019中国肿瘤学大会 年份：2019
...
Prognostic value of primary tumor surgery in seminoma patients with distant metastasis at diagnosis:
[会议论文] 作者：Jiaming Wei,Shengming Jin,Junlong Wu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
Objective In this study,we used population-based data from the Surveillance,Epidemiology and End Results(SEER)database to explore the prognostic value and identify optimal candidates of PTS for semino...
[会议论文] 作者：SHENGMING JIN,JUNLONG WU,WEIJIE GU,DINGWEI YE,
来源：2019中国肿瘤学大会 年份：2019
...
[会议论文] 作者：Beihe Wang,Yao Zhu,Jun Luo,Stephen Freedland,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
10-immune related gene expression panel to predict the overall survival and tumor recurrence in pati
[会议论文] 作者：Yu Zhu,Junyu Zhang,Chengyuan Gu,Yiping Zhu,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
Objective Bladder cancer is diagnosed in more than 430,000 patients worldwide each year.Although representing only about 25%of patients,patients with muscle invasive bladder cancer(MIBC)have a much wo...
[会议论文] 作者：Fangning WAN,Huyang Xie,Beihe Wang,Yiping Zhu,Yijun Shen,Dingwei Ye,
来源：2019中国肿瘤学大会 年份：2019
...
Effect of body mass index on the performance characteristics of prostate-specific antigen-related ma
[会议论文] 作者：yao zhu,Chengtao Han,Guiming Zhang,Fang Liu,Qiang Ding,Jianfeng Xu,Dingwei Ye,
来源：CUA2015全国泌尿男生殖系统肿瘤专题会议(10th)暨2015年广东省医学会泌尿外科学学术年会 年份：2015
Objectives: To examine whether the predictive performance of prostate-specific antigen (PSA) and PSA-related markers for prostate cancer (PCa) is modified by body mass index (BMI).Patients and Methods...
相关搜索：
